Roche and Synta Pharmaceuticals entered an agreement potentially worth $1.025 billion to discover, develop, and commercialize small molecule anti-inflammatories. Roche will pay Synta $25 million upfront, which includes $9 million in research funding ...
Read more...
Helping adolescents with arthritis develop the skills and secure resources to assure that their health care needs are met as they transition to adulthood is an important issue in the U.S. In general, the frequency of which young people with special ...
Read more...
VIENNA, Va. , Jan. 7 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Alternext US : CVM ) announced today the initiation of a definitive study of its new rheumatoid arthritis treatment vaccine (CEL-2000) to determine the long-lasting beneficial ...
Read more...
ANN ARBOR, Mich. January 07, 2009 /PRNewswire/ -- Velcura Therapeutics Inc., a clinical-phase biotechnology company developing therapies for bone disease, has completed its second successful Investigational New Drug application (IND) to the U.S. Food ...
Read more...
Total knee replacement (TKR) is a common treatment for osteoarthritis, a disease affecting more than 20 million Americans. However, the surgery poses risks and both patients and physicians must carefully assess its potential benefits and harm ...
Read more...
Abbott Laboratories sued Bayer AG's HealthCare unit, challenging a demand for patent royalties on its top-selling arthritis drug Humira. Bayer, Germany's largest drugmaker and the inventor of aspirin, sued Libertyville Township-based Abbott in a Dec ...
Read more...
The Arthritis Foundation's Long Island Chapter announced the upcoming launch of Let's Move Together, a nationwide movement created to improve the quality of life of the one-in-five Americans suffering from the pain of arthritis. Let's Move Together ...
Read more...